Clinical Trials

Clinical Research Trials Search Results

Page of 3, showing items 1-10 of 30.
  • Alliance 151216/ ALCHEMIST Alliance A081105, A081801 & ECOG E4512

    The ALCHEMIST trials are testing therapies that target two types of genetic changes that are thought to drive lung cancer growth: mutations in the EGFR gene and a rearrangement of the ALK gene.

  • AFT-25/COMET

    This study looks at the risks and benefits of active surveillance (AS) compared to guideline concordant care (GCC) in the setting of a pragmatic prospective randomized trial for low risk DCIS.

  • ACCRU SC-1601 EVE Trial

    A randomized phase III trial studying the best dose of apixaban and how well it works in preventing secondary cancer related blood clots in cancer patients who have completed anticoagulation therapy.

  • AFT-19

    A study in men with biochemically recurrent prostate cancer and PSA doubling time = 9 months at the time of study entry.


    This precision medicine cancer treatment trial seeks to determine whether treating cancer based on specific genetic changes is effective.

  • Alliance A031501

    A trial studying how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes.

  • CA209-901

    A trial studying if an investigational immunotherapy is more effective than standard chemotherapy in treating patients with metastatic urothelial cancer.

  • SWOG S1418

    This randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer.

  • SWOG S1802

    This phase III trial studies how well standard systemic therapy with or without definitive treatment works in treating participants with prostate cancer that has spread.


    A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL).

Page of 3, showing items 1-10 of 30.